Tag: Stereotaxis

Stereotaxis Announces Partnership with Kansas City Heart Rhythm Institute to Bring New Treatment to Arrhythmia Patients

ST. LOUIS, Jan. 24, 2019 (GLOBE NEWSWIRE) — Stereotaxis (OTCQX: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias announced today a partnership with Kansas City Heart Rhythm Institute to bring new and cutting-edge treatments to arrhythmia patients. Kansas City Heart Rhythm Institute (KCHRI), a […]

Stereotaxis to Present at the 11th Annual LD Micro Main Event Investor Conference

ST. LOUIS, Nov. 26, 2018 (GLOBE NEWSWIRE) — Stereotaxis, Inc. (OTCQX: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that David Fischel, Chairman and Chief Executive Officer, is scheduled to present at the 11th Annual LD Micro Main Event investor conference. Mr. Fischel […]

Stereotaxis to Present at OTCQX Virtual Investor Conference for Domestic Companies

ST. LOUIS, Mo., Sept. 25, 2018 (GLOBE NEWSWIRE) — Stereotaxis, Inc. (OTCQX: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that it will present at the OTCQX Virtual Investor Conference for Domestic Companies. Management will provide an overview of the Company’s technology […]

Stereotaxis and Johnson & Johnson’s Biosense Webster Extend Development Alliance and Supply Agreement

ST. LOUIS, June 25, 2018 (GLOBE NEWSWIRE) — Stereotaxis, Inc. (OTCQX:STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, announced today that it has entered into an amendment to the long-term Development Alliance and Supply Agreement with Johnson & Johnson’s Biosense Webster, Inc. The amendment […]